BA (Cum Laude), MA, MSc, PhD
- Mixed Methods Researcher for IMI PARADIGM
- Qualitative Researcher for Oxford-Celgene Clinical Research Fellow Programme project
Dr Suzanne Ii is a senior researcher in the Interdisciplinary Research in Health Sciences (IRIHS) Group in the Department of Primary Care Health Sciences. Currently, she is part of a 30-month, EU-wide consortium project called IMI PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines). She uses quantitative and qualitative methodologies to understand the current patient engagement landscape in the medicines lifecycle among nine stakeholder groups.
Suzanne is also the lead researcher on the Oxford-Celgene Clinical Research Fellowship Programme. The focus is on understanding the potential for clinical and academic research fellows to become boundary spanners by gaining experience through an industry-funded fellowship programme. The study is a multi-phase 3-year longitudinal project and mixes qualitative methods, evaluation tools and life journey plots to understand the career, aspirations, network and relationships of the Fellows. There is also a formative assessment conducted that asks the Fellows, Principal Investigators and Industry Mentors their thoughts on the programme and quality improvement.
Her previous work explored perceptions of tri-sectoral collaborations between academia, healthcare and industry to understand the barriers and facilitators to medical innovation adoption in the NHS. Applied knowledge mobilisation theory was used to develop recommendations for current innovation adoption policies.
Suzanne holds a BA in Anthropology, specialising in Physical Anthropology with a minor in Japanese from California State University, Fresno. She holds an MA degree in East Asian Studies from Stanford University. Suzanne also holds an MSc degree in Visual Anthropology from the University of Oxford. She completed her doctoral studies at the Institute of Psychiatry, Psychology and Neuroscience's National Addiction Centre, King's College London, earning her a PhD in Addiction Sciences. She used quantitative and qualitative research methods and an applied theoretical framework to explore the dietary and nutrient intake, dietary behaviours and physical changes that occurred in people receiving opioid agonist treatment therapy.
Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption
(2018), Health Policy, 122, 175 - 183
Cancer as the "perfect storm"? A qualitative study of public attitudes to health conditions.
Morrell L. et al, (2018), Health Sci Rep, 1
Diet and nutrient intake of people receiving opioid agonist treatment (OAT): implications for recovery
(2016), Drugs and Alcohol Today, 16, 59 - 71